Trial Profile
PHASE II MULTICENTRIC AND PROSPECTIVE TRIAL WITH GEMCITABINE AND RAPAMYCIN IN SECOND LINE OF METASTATIC OSTEOSARCOMA [ENSAYO FASE II MULTICENTRICO Y PROSPECTIVO CON GEMCITABINA Y RAPAMICINA EN SEGUNDA LINEA DE OSTEOSARCOMA METASTASICO]
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 27 Sep 2013
Price :
$35
*
At a glance
- Drugs Gemcitabine (Primary) ; Sirolimus (Primary)
- Indications Osteosarcoma
- Focus Therapeutic Use
- 19 Jul 2012 New trial record